| FoxM1: Repurposing an oncogene as a biomarker D Nandi, PS Cheema, N Jaiswal, A Nag Seminars in Cancer Biology 52, 74-84, 2018 | 131 | 2018 |
| Significance of human microbiome in breast cancer: Tale of an invisible and an invincible J Chadha, D Nandi, Y Atri, A Nag Seminars in Cancer Biology 70, 112-127, 2021 | 43 | 2021 |
| Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19 PS Cheema, D Nandi, A Nag Open biology 11 (6), 210069, 2021 | 32 | 2021 |
| The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful! D Nandi, S Parida, D Sharma Gut Microbes 15 (1), 2221452, 2023 | 24 | 2023 |
| The pint-sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti-cancer therapy I Chattopadhyay, D Nandi, A Nag Seminars in cancer biology 70, 98-111, 2021 | 17 | 2021 |
| Artemisinin mediates its tumor-suppressive activity in hepatocellular carcinoma through targeted inhibition of FoxM1 D Nandi, PS Cheema, A Singal, H Bharti, A Nag Frontiers in Oncology 11, 751271, 2021 | 13 | 2021 |
| Tale of a multifaceted co-activator, hADA3: from embryogenesis to cancer and beyond V Chand, D Nandi, AG Mangla, P Sharma, A Nag Open Biology 6 (9), 160153, 2016 | 6 | 2016 |
| The anaphase-promoting complex/cyclosome co-activator, Cdh1, is a novel target of human papillomavirus 16 E7 oncoprotein in cervical oncogenesis N Jaiswal, D Nandi, PS Cheema, A Nag Carcinogenesis 43 (10), 988-1001, 2022 | 5 | 2022 |
| Identification of novel interaction between Promyelocytic Leukemia protein and human Alteration/Deficiency in Activation 3 coactivator and its role in DNA damage response V Chand, PS Cheema, Y Atri, D Nandi, P Sharma, N Jaiswal, R John, ... Journal of Proteins and Proteomics 10, 207-220, 2019 | 1 | 2019 |
| Enterotoxigenic Bacteroides fragilis, a colon microbe, dysregulates polyamine catabolism to promote breast cancer progression D Nandi, S Parida, S Thatikonda, J Foley, T Stewart, CL Sears, ... Cancer Research 83 (7_Supplement), 5905-5905, 2023 | | 2023 |
| Drug Resistance in Cancer and Role of Nanomedicine-Based Natural Products D Nandi, A Singal, A Nag Bioactive Natural Products for the Management of Cancer: from Bench to …, 2019 | | 2019 |
| Integrating immunotherapy with conventional treatment regime for breast cancer patients-an amalgamation of armamentarium D Sharma, D Nandi Frontiers in Immunology 15, 1477980, 0 | | |
